Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
The 7000-dollar Halloween party favor
New Jerseyan charged with insider trading on San Diego biotech buyout
On June 19, 2012, a promising San Diego biotech, Ardea Biosciences, working on gout and cancer medicines, was bought for $1.26 billion in cash by London-based pharmaceutical company AstraZeneca.
According to charges filed October 24 by the Securities and Exchange Commission (SEC), David Post of Livingston, New Jersey, was tipped off on the Ardea acquisition and raked in big bucks buying in advance of the deal. All told, he rolled up $700,000 in illicit profits doing insider trading on the Astrea deal and one other.
He was tipped off by a friend, Zachary Zwerko, who worked for a pharmaceutical company and knew of a bidding war going on for Ardea. His own company was one of the bidders.
In the weeks before the AstraZeneca deal, Post bought $227,000 worth of Ardea securities, then dumped them for $105,000 in profits, says the SEC. Post and Zwerko used coded messages to communicate by phone and email. Post paid Zwerko $7000 at a Halloween party and later gave him $50,000 in a shoebox.
Here's something you might be interested in.
The 7000-dollar Halloween party favor
New Jerseyan charged with insider trading on San Diego biotech buyout
The 7000-dollar Halloween party favor
New Jerseyan charged with insider trading on San Diego biotech buyout
On June 19, 2012, a promising San Diego biotech, Ardea Biosciences, working on gout and cancer medicines, was bought for $1.26 billion in cash by London-based pharmaceutical company AstraZeneca.
According to charges filed October 24 by the Securities and Exchange Commission (SEC), David Post of Livingston, New Jersey, was tipped off on the Ardea acquisition and raked in big bucks buying in advance of the deal. All told, he rolled up $700,000 in illicit profits doing insider trading on the Astrea deal and one other.
He was tipped off by a friend, Zachary Zwerko, who worked for a pharmaceutical company and knew of a bidding war going on for Ardea. His own company was one of the bidders.
In the weeks before the AstraZeneca deal, Post bought $227,000 worth of Ardea securities, then dumped them for $105,000 in profits, says the SEC. Post and Zwerko used coded messages to communicate by phone and email. Post paid Zwerko $7000 at a Halloween party and later gave him $50,000 in a shoebox.
Comments